Inogen (INGN) EBITDA Margin Growth (1y) (2014 - 2026)
Inogen (INGN) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 146.00 |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | 128.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 128.00 |
| Mar 31, 2026 | -166.00 |
| Dec 31, 2025 | 283.00 |
| Sep 30, 2025 | 107.00 |
| Jun 30, 2025 | 132.00 |
| Mar 31, 2025 | 1,155.00 |
| Dec 31, 2024 | 2,397.00 |
| Sep 30, 2024 | 4,687.00 |
| Jun 30, 2024 | 611.00 |
| Mar 31, 2024 | 951.00 |
| Dec 31, 2023 | 2,821.00 |
| Sep 30, 2023 | -4,588.00 |
| Jun 30, 2023 | -1,129.00 |
| Mar 31, 2023 | -1,347.00 |
| Dec 31, 2022 | -6,031.00 |
| Sep 30, 2022 | -1,764.00 |
| Jun 30, 2022 | -1,427.00 |
| Mar 31, 2022 | -1,445.00 |
| Dec 31, 2021 | 138.00 |
| Sep 30, 2021 | 1,082.00 |